ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IPS Ipso Ventures

1.425
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Ipso Ventures LSE:IPS London Ordinary Share GB00B1GDWB47 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.425 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Ipso Ventures Share Discussion Threads

Showing 1776 to 1794 of 2275 messages
Chat Pages: Latest  79  78  77  76  75  74  73  72  71  70  69  68  Older
DateSubjectAuthorDiscuss
22/11/2011
22:32
Now the Pharmacies are all rolling it out too.

NPA-National Pharmacy Association Documents.

Buccolam (midazolam) oromucosal (buccal) solution 5mg/1ml has recently been granted a paediatric use marketing authorisation (PUMA) by the European Commission, and as such is now classed as a licensed product.
The following FAQs will assist when deciding what product to supply against either a requisition or a prescription.

topinfo
22/11/2011
22:32
Here we go, the evening pump and dump shift second gang member topinfo
is here to spam more rubbish !

Strange how each time he does this he vanishes after a load of sales
the next morning.

Just testing here, is there anybody lurking that would buy this because
of what well known pump and dumpers will paste here tonight.

m4 and topinfo are conmen !

kinghorm23
22/11/2011
22:29
Now here comes the real good stuff by way of a few hours further research on IPS this evening.

Now we all know what Buccolam is used for and why it will become the drug that is prescribed now it has full EU approval. It is now licensed and the roll out to the NHS etc begins.



MHRA Drug Safety Update (October 2011): Care needed when transferring from unlicensed formulations of buccal midazolam to licensed product (Buccolam) for paediatric use

topinfo
22/11/2011
22:17
ps...your posts suggest you are seriously deranged and very paranoid m4 !
kinghorm23
22/11/2011
22:16
It's sheer on ludicrous that you and topinfo have the arrogance to think
you can come and come at will and pump and dump this stock when all your
pump and dump posts are still splattered all over this thread.

Honesty M4 i think you are absolute scum, the lowest parasite of them
all to be part of a serial pump and dump group.

kinghorm23
22/11/2011
12:36
yep opened it tops

thanks

moreforus
22/11/2011
12:34
I cant seem to copy link so you have to get it by downloading it and opening it in Acrobat.


Transfer to new Licensed Buccal Midazolam 5mg/ml (Buccolam ...
www.elmmb.nhs.uk/EasySiteWeb/GatewayLink.aspx?alId=48788
You +1'd this publicly. Undo
File Format: PDF/Adobe Acrobat - View as HTML
4 days ago - Buccal midazolam (Buccolam▼) is a new licensed treatment for prolonged acute ... Buccolam is half the strength of some other unlicensed preparations. ...
#
Epilepsy - NeLM

topinfo
22/11/2011
12:30
Thats Buccolam. If thats the NHS now using it, imagine royalties to Therakind!
topinfo
22/11/2011
12:25
NHS

Copy and paste that link

www.elmmb.nhs.uk/EasySiteWeb/GatewayLink.aspx?alId=48788

topinfo
22/11/2011
12:25
Just found some very interesting stuff out as well M4.
topinfo
22/11/2011
12:22
The thing I notice about IPS is it needs a bombing before a good rise. Its had the bombing and here comes the rise again!
topinfo
18/11/2011
07:45
No sign of the pump and dumpers now eh.

News this morning, from the 1st but at 3.75p so it might give the share
a lift, not sure.

The Board of IPSO announces that it has today issued a total of 800,000 new ordinary shares of 0.1 pence each in IPSO (the "New Ordinary Shares") to the existing directors of IPSO and a former director in lieu of net fees payable for the three month period ended 31 October 2011. The New Ordinary Shares were issued at a price of 3.75 pence, being the closing mid-market price of IPSO's ordinary shares on 1 November 2011.

kinghorm23
16/11/2011
22:39
Normally the time to buy though, buy at 3p or less and sell at 4p or
more on the next spike, usually sticks to that pattern.

And any news would certainly help that as well.

kinghorm23
16/11/2011
21:50
Mooochy... it seems all the weak holders have exited.. only the optimists remain... let me guess... Fridays are a strong day... so not long to wait....

here we are ... sub 3p.... by the way I wouldnt pay £100 at this price...

Cash is burning away...Anyone post about the reduction in FIT which will be a devastating blow for the Ipsol business.... nah... shares being shuffled.... it really isnt looking good now.........

electrick
16/11/2011
12:37
MMs trying to shake weak holders out here so it would seem.
moochy
15/11/2011
10:03
The change of registered office and now directors moving chunks of shares around to obviuosly create losses or if the shares shoot up match those gains with losses available elsewhere. You wouldn't do that if you thought something was a foot that would enable your plans to come to fruition.

Is this good or bad?

Who knows but if it is to move the potential wealth around the family then it is being done at a time when the shares and thus any capital gains created are at their lowest. If it it is being to to maximise the potential available tax losses as you know the compnay is a dead duck then we should all scarper as well.

I think some good news is on the way and that is why things are being moved around.

fur
14/11/2011
14:56
DJ Ipso Ventures PLC Director/PDMR Shareholding

TIDMIPS

RNS Number : 0514S

Ipso Ventures PLC

14 November 2011

14 November 2011

IPSO Ventures plc

("IPSO" or the "Company")

Director's dealing

Holding in Company

The Board of IPSO announces that Craig Rochford, Chairman of IPSO, sold 1,675,000 ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") on 11 November 2011 to Buckton Homes Limited at a price of 1 pence per Ordinary Share in an off-market transaction (the "Share Transaction").

Buckton Homes Limited, a company wholly owned by the adult children of Fred Stirling, holds a total beneficial interest in 1,675,000 Ordinary Shares in the Company following the Share Transaction, equivalent to 4.45% of IPSO's total issued share capital.

In addition, the Company was notified today that, on 11 November 2011, Craig Rochford transferred 50,000 Ordinary Shares held by Arka Technologies Limited, a company wholly owned by Craig Rochford, into his personal name in an off-market transaction at a price of 3.5 pence per Ordinary Share (the "Transfer").

Following the Share Transaction and the Transfer, Craig Rochford holds a total beneficial interest in 2,405,000 Ordinary Shares in the Company equivalent to 6.39 per cent. of IPSO's total issued share capital. 480,000 of the Ordinary Shares are held by The Invention Company Limited, a company wholly owned by Craig Rochford.

For further information, please contact:

day7rader
10/11/2011
11:06
Hi Nopolipo, to be honest I don't know that much about the plus market either. what I do know is that "PLUS is a London-based stock exchange providing cash trading and listing, derivatives and technology services. PLUS delivers product innovation and competitive pricing to market participants by operating a low cost base RIE. PLUS offers a neutral trading environment, wholly independent of any market user." This is quoted from their website-link below.
moochy
10/11/2011
07:50
3.38 close...... perhaps today will be the day for sub 3p
electrick
Chat Pages: Latest  79  78  77  76  75  74  73  72  71  70  69  68  Older

Your Recent History

Delayed Upgrade Clock